Palvella Therapeutics Inc (PIRS)
Market Closed
13 Dec, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
13. 60
-2.51
-15.58%
Pre Market
$
+1.4 +10.29% 15. 00
17.96M Market Cap
- P/E Ratio
0% Div Yield
51,728 Volume
-0.35 Eps
$ 16.11
Previous Close Day Range
13.26 15.35
Year Range
6.2 22.32
Want to track PIRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Is Pieris Pharmaceuticals (PIRS) Stock Up 77% Today?
Pieris Pharmaceuticals (NASDAQ: PIRS ) stock is rocketing higher on Wednesday after announcing a merger agreement with Palvella Therapeutics. Pieris Pharmaceuticals and Palvella Therapeutics will enact an all-stock transfer for this merger.
Investorplace | 1 year ago
